BioSpace News Archive

Business

Exagen Announces Appointment of John Aballi as CEO

Exagen Inc. (Nasdaq: XGN), announced today that the company has appointed John Aballi as CEO and President. Longtime CEO and President Ron Rocca, who took the company public and built a robust growth business, is stepping down after 11 years at the helm.

October 17, 2022
·
5 min read
Business

Qihan Biotech Appoints Tony W. Ho to its Board of Directors

Hangzhou Qihan Biotech Co., Ltd. (“Qihan” or “Qihan Biotech” or “the Company”), an industry leader in applying multiplexable genome editing technology to cell therapies and organ transplantation, today announced the appointment of Tony W. Ho, M.D., to its Board of Directors as an independent director.

October 17, 2022
·
5 min read
Policy

FDA Awards 19 Grants and Two Contracts Related to Rare Diseases, including ALS

The U.S. Food and Drug Administration announced it has awarded 19 new grants and two new contracts totaling more than $38 million in funding over the next four years to support clinical trials, natural history studies and regulatory science tools related to rare diseases.

October 17, 2022
·
5 min read
Drug Development

Kiora Pharmaceuticals Announces Publication of Phase 1 Trial Results for KIO-100 as a Treatment for Ocular Inflammatory Disease

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) announced that results from a Phase 1 study of KIO-100 (formerly PP-001) demonstrate its potential as a treatment for non-infectious uveitis, an ophthalmic inflammatory disease.

October 17, 2022
·
6 min read
BioForest

Gestalt Diagnostics Debuts PathFlow Version 5.0 at Pathology Visions 2022

Gestalt Diagnostics, Inc., will be debuting the newest version of PathFlow, our award-winning, pathologist-proven digital pathology solution during the Digital Pathology Association’s Pathology Visions 22 Conference in Las Vegas, October 16-18, 2022.

October 17, 2022
·
2 min read
Advanced Glycation End Products Market Size to Hit USD 2.30 Billion by 2027

According to Nova one advisor, the global Advanced Glycation End Products market was valued at USD 1.50 Billion in 2020 and it is expected to hit around USD 2.30 billion by 2030 with a CAGR of 5.0% during the forecast period 2022 to 2030.

October 17, 2022
·
6 min read
Biotherapeutics Cell Line Development Market Size & Growth Forecast, 2030

According to Nova one advisor, the global Biotherapeutics Cell Line Development market size is expected to hit around USD 415 million by 2030 from valued at USD 210 million in 2021 and growing at a CAGR of 10.4% from 2022 to 2030.

October 17, 2022
·
8 min read
Membrane Filtration Market Size to Hit USD 36.9 Bn by 2030

According to Nova one advisor, the global Membrane Filtration market was valued at USD 16 .9 billion in 2021 and it is expected to hit around USD 36.9 billion by 2030 with a CAGR of 9.29% during the forecast period 2022 to 2030.

October 17, 2022
·
7 min read
Oral Thin Films Market Size to Hit USD 5.9 Billion by 2027

According to Nova one advisor, the global Oral Thin Films market was valued at USD 3.0 billion in 2020 and it is expected to hit around USD 5.9 billion by 2027 with a CAGR of 8.7% during the forecast period 2022 to 2030.

October 17, 2022
·
6 min read
Respiratory Virus Infection Drugs Market Size & Growth Forecast, 2030

The global Respiratory Virus Infection Drugs market gathered revenue around USD 39.2 Billion in 2020 and market is set to grow USD 81.2 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 6.9% during the prediction period 2021 to 2027.

October 17, 2022
·
6 min read